The neurogenic bladder: An update with management strategies for primary care physicians

Medical Clinics of North America

Volumn 95, Issue 1, 2011, Pages 111-120

  Klausner, Adam P ^a   Steers, William D ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Bladder outlet obstruction; Neurogenic bladder; Urodynamics

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIBIOTIC AGENT; BOTULINUM TOXIN; GLYCERYL TRINITRATE; MUSCARINIC RECEPTOR BLOCKING AGENT; NIFEDIPINE;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; AUTONOMIC DYSREFLEXIA; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BLADDER CAPACITY; BLADDER PRESSURE; BLADDER SPHINCTER; CASE REPORT; CEREBROVASCULAR DISEASE; CLINICAL PRACTICE; CYSTOMETRY; DETRUSOR DYSSYNERGIA; DETRUSOR MUSCLE; DIFFERENTIAL DIAGNOSIS; ELECTROMYOGRAPHY; FEMALE; FLUID INTAKE; HUMAN; HYDRONEPHROSIS; HYPERTENSION; INDWELLING CATHETER; INTERMITTENT CATHETERIZATION; KIDNEY INJURY; LOW DRUG DOSE; MALE; MICTURITION REFLEX; NEUROGENIC BLADDER; NEUROLOGIC DISEASE; NEUROMODULATION; OFF LABEL DRUG USE; PARAPLEGIA; PATIENT COUNSELING; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTEUS; REVIEW; RISK FACTOR; SPHINCTEROTOMY; SPINAL CORD INJURY; STENT; STROKE; TREATMENT INDICATION; URETHRAL STENT; URINARY CATHETER; URINARY DIVERSION; URINARY TRACT INFECTION; URODYNAMICS;

ADULT; AGED, 80 AND OVER; CATHETERS, INDWELLING; FEMALE; HUMANS; MALE; PRIMARY HEALTH CARE; URINARY BLADDER, NEUROGENIC; URINARY TRACT INFECTIONS; URODYNAMICS;

EID: 78649361283     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2010.08.027     Document Type: Review

References (46)

1. Mallory B.S., Roppolo J.R., de Groat W.C. Pharmacological modulation of the pontine micturition center. Brain Res 1991, 546(2):310-320.
2. Abrams P., Cardozo L., Fall M., et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002, 21(2):167-178.
3. Blanker M.H., Groeneveld F.P., Bohnen A.M., et al. Voided volumes: normal values and relation to lower urinary tract symptoms in elderly men, a community-based study. Urology 2001, 57(6):1093-1098. [discussion: 1098-9].
4. Damaser M.S. Whole bladder mechanics during filling. Scand J Urol Nephrol Suppl 1999, 201:51-58. [discussion: 76-102].
5. Wein A.J. Lower urinary tract dysfunction in neurologic injury and disease. Campbell-Walsh urology 2007, 2014-2017. Saunders Elsevier, Philadelphia, 2037. 9th edition. A.J. Wein, A. Partin, C. Peters, et al (Eds.).
6. Heslington K., Hilton P. Ambulatory monitoring and conventional cystometry in asymptomatic female volunteers. Br J Obstet Gynaecol 1996, 103(5):434-441.
7. Robertson A.S., Griffiths C.J., Ramsden P.D., et al. Bladder function in healthy volunteers: ambulatory monitoring and conventional urodynamic studies. Br J Urol 1994, 73(3):242-249.
8. Griffiths D., Höfner K., van Mastrigt R., et al. Standardization of terminology of lower urinary tract function: pressure-flow studies of voiding, urethral resistance, and urethral obstruction. International Continence Society Subcommittee on Standardization of Terminology of Pressure-Flow Studies. Neurourol Urodyn 1997, 16(1):1-18.
9. Klausner A.P., Steers W.D. Antimuscarinics for the treatment of overactive bladder: a review of central nervous system effects. Curr Urol Rep 2007, 8(6):441-447.
10. Campbell J.D., Gries K.S., Watanabe J.H., et al. Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence. BMC Urol 2009, 9:18.
11. Peters K.M., Carrico D.J., Perez-Marrero R.A., et al. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol 2010, 183(4):1438-1443.
12. Bennett N., O'Leary M., Patel A.S., et al. Can higher doses of oxybutynin improve efficacy in neurogenic bladder?. J Urol 2004, 171(2 Pt 1):749-751.
13. Hackler R.H., Hall M.K., Zampieri T.A. Bladder hypocompliance in the spinal cord injury population. J Urol 1989, 141(6):1390-1393.
14. Weld K.J., Graney M.J., Dmochowski R.R. Differences in bladder compliance with time and associations of bladder management with compliance in spinal cord injured patients. J Urol 2000, 163(4):1228-1233.
15. Wyndaele J.J. Correlation between clinical neurological data and urodynamic function in spinal cord injured patients. Spinal Cord 1997, 35(4):213-216.
16. Linsenmeyer T.A., Bagaria S.P., Gendron B. The impact of urodynamic parameters on the upper tracts of spinal cord injured men who void reflexly. J Spinal Cord Med 1998, 21(1):15-20.
17. Buczynski A.Z. Urodynamic studies in evaluating detrusor sphincter dyssynergia and their effects on the treatment. Paraplegia 1984, 22(3):168-172.
18. Rivas D.A., Chancellor M.B. Neurogenic vesical dysfunction. Urol Clin North Am 1995, 22(3):579-591.
19. Bennett J.K., Foote J., El-Leithy T.R., et al. Terazosin for vesicosphincter dyssynergia in spinal cord-injured male patients. Mol Urol 2000, 4(4):415-420.
20. Chancellor M.B., Erhard M.J., Rivas D.A. Clinical effect of alpha-1 antagonism by terazosin on external and internal urinary sphincter function. J Am Paraplegia Soc 1993, 16(4):207-214.
21. Perkash I. Efficacy and safety of terazosin to improve voiding in spinal cord injury patients. J Spinal Cord Med 1995, 18(4):236-239.
22. Swierzewski S.J., Gormley E.A., Belville W.D., et al. The effect of terazosin on bladder function in the spinal cord injured patient. J Urol 1994, 151(4):951-954.
23. Smith C.P., Nishiguchi J., O'Leary M., et al. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology 2005, 65(1):37-41.
24. Kuo H.C. Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction. J Urol 2003, 170(5):1908-1912.
25. Chancellor M.B., Gajewski J., Ackman C.F., et al. Long-term followup of the North American multicenter UroLume trial for the treatment of external detrusor-sphincter dyssynergia. J Urol 1999, 161(5):1545-1550.
26. McGuire E.J., Woodside J.R., Borden T.A., et al. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol 1981, 126(2):205-209.
27. Kim Y.H., Kattan M.W., Boone T.B. Bladder leak point pressure: the measure for sphincterotomy success in spinal cord injured patients with external detrusor-sphincter dyssynergia. J Urol 1998, 159(2):493-496. [discussion: 496-7].
28. Shingleton W.B., Bodner D.R. The development of urologic complications in relationship to bladder pressure in spinal cord injured patients. J Am Paraplegia Soc 1993, 16(1):14-17.
29. Jacobs S.C., Kaufman J.M. Complications of permanent bladder catheter drainage in spinal cord injury patients. J Urol 1978, 119(6):740-741.
30. Selzman A.A., Hampel N. Urologic complications of spinal cord injury. Urol Clin North Am 1993, 20(3):453-464.
31. Vaidyanathan S., Mansour P., Soni B.M., et al. The method of bladder drainage in spinal cord injury patients may influence the histological changes in the mucosa of neuropathic bladder - a hypothesis. BMC Urol 2002, 2:5.
32. Cardenas D.D., Hooton T.M. Urinary tract infection in persons with spinal cord injury. Arch Phys Med Rehabil 1995, 76(3):272-280.
33. Wall B.M., Huch K.M., Mangold T.A., et al. Risk factors for development of proteinuria in chronic spinal cord injury. Am J Kidney Dis 1999, 33(5):899-903.
34. Chao R., Clowers D., Mayo M.E. Fate of upper urinary tracts in patients with indwelling catheters after spinal cord injury. Urology 1993, 42(3):259-262.
35. Donnellan S.M., Bolton D.M. The impact of contemporary bladder management techniques on struvite calculi associated with spinal cord injury. BJU Int 1999, 84(3):280-285.
36. Hess M.J., Zhan E.H., Foo D.K., et al. Bladder cancer in patients with spinal cord injury. J Spinal Cord Med 2003, 26(4):335-338.
37. Andrews H.O., Nauth-Misir R., Shah P.J. Iatrogenic hypospadias-a preventable injury?. Spinal Cord 1998, 36(3):177-180.
38. Lapides J., Diokno A.C., Silber S.J., et al. Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol 1972, 107(3):458-461.
39. Kovindha A., Mai W.N., Madersbacher H. Reused silicone catheter for clean intermittent catheterization (CIC): is it safe for spinal cord-injured (SCI) men?. Spinal Cord 2004, 42(11):638-642.
40. Kuhn W., Rist M., Zaech G.A. Intermittent urethral self-catheterisation: long term results (bacteriological evolution, continence, acceptance, complications). Paraplegia 1991, 29(4):222-232.
41. Perrouin-Verbe B., Labat J.J., Richard I., et al. Clean intermittent catheterisation from the acute period in spinal cord injury patients. Long term evaluation of urethral and genital tolerance. Paraplegia 1995, 33(11):619-624.
42. Feifer A., Corcos J. Contemporary role of suprapubic cystostomy in treatment of neuropathic bladder dysfunction in spinal cord injured patients. Neurourol Urodyn 2008, 27(6):475-479.
43. Liedl B. Catheter-associated urinary tract infections. Curr Opin Urol 2001, 11(1):75-79.
44. Morton S.C., Shekelle P.G., Adams J.L., et al. Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction. Arch Phys Med Rehabil 2002, 83(1):129-138.
45. Lee B.B., Haran M.J., Hunt L.M., et al. Spinal-injured neuropathic bladder antisepsis (SINBA) trial. Spinal Cord 2007, 45(8):542-550.
46. Krassioukov A., Warburton D.E., Teasell R., et al. A systematic review of the management of autonomic dysreflexia after spinal cord injury. Arch Phys Med Rehabil 2009, 90(4):682-695.